Mirjam Talvik

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography
    Mirjam Talvik
    Karolinska Institute, Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital R4, SE 171 76 Stockholm, Sweden
    Psychiatry Res 148:165-73. 2006
  2. ncbi Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457
    Mirjam Talvik
    Department of Clinical Neuroscience, Psychiatry Section, Karolinska Psychiatric Centre, Karolinska Hospital, S 171 76 Stockholm, Sweden
    Int J Neuropsychopharmacol 6:361-70. 2003
  3. ncbi A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration
    Mirjam Talvik
    Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institute, S 171 76 Stockholm, Sweden
    Psychopharmacology (Berl) 175:148-53. 2004

Detail Information

Publications3

  1. ncbi Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography
    Mirjam Talvik
    Karolinska Institute, Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital R4, SE 171 76 Stockholm, Sweden
    Psychiatry Res 148:165-73. 2006
    ....
  2. ncbi Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457
    Mirjam Talvik
    Department of Clinical Neuroscience, Psychiatry Section, Karolinska Psychiatric Centre, Karolinska Hospital, S 171 76 Stockholm, Sweden
    Int J Neuropsychopharmacol 6:361-70. 2003
    ..The preliminary finding of low thalamic D2/D3 BP in patients strengthens the hypothesis that the thalamus is a key region in the pathophysiology of schizophrenia...
  3. ncbi A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration
    Mirjam Talvik
    Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institute, S 171 76 Stockholm, Sweden
    Psychopharmacology (Berl) 175:148-53. 2004
    ..Serum concentrations at low dose levels may therefore serve as a useful tool in clinical monitoring of antipsychotic drug treatment...